S-4 filed Sep 14, 2026 at 07:01 ET
Medtronic plc is offering to exchange up to 225,361,295 newly issued shares of MiniMed common stock for outstanding Medtronic ordinary shares at a 7% discount to MiniMed's three-day VWAP, subject to an upper limit of 4.5939 MiniMed shares per Medtronic share. The exchange offer is the primary mechanism for Medtronic's tax-efficient divestiture of its ~89.86% stake in MiniMed, creating an independent diabetes-focused company. The filing also includes MiniMed's financials showing strong 16.6% revenue growth in the latest quarter, driven by international sales and new product launches, though the company remains unprofitable on a GAAP basis.